Select a section from the left sidebar
Arjunolic acid
- Family: Plantae - Combretaceae
- Kingdom: Plantae
-
Class: Terpenoid
- Subclass: Triterpene
Canonical Smiles | C[C@@]12CC[C@@H]3[C@@]([C@H]1CC=C4[C@]2(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)(C[C@H]([C@@H]([C@@]3(C)CO)O)O)C |
---|---|
InChI | InChI=1S/C30H48O5/c1-25(2)11-13-30(24(34)35)14-12-28(5)18(19(30)15-25)7-8-22-26(3)16-20(32)23(33)27(4,17-31)21(26)9-10-29(22,28)6/h7,19-23,31-33H,8-17H2,1-6H3,(H,34,35)/t19-,20+,21+,22+,23-,26-,27-,28+,29+,30-/m0/s1 |
InChIKey | RWNHLTKFBKYDOJ-DDHMHSPCSA-N |
Formula | C30H48O5 |
HBA | 4 |
HBD | 4 |
MW | 488.71 |
Rotatable Bonds | 2 |
TPSA | 97.99 |
LogP | 5.18 |
Number Rings | 5 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Fraction CSP3 | 0.9 |
Exact Mass | 488.35 |
Number of Lipinski Rule Violations | 1 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Plumeria rubra | Apocynaceae | Plantae | 62097 |
2 | Dissotis thollonii | Melastomaceae | Plantae | 2015423 |
3 | Combretum dolichopetalum | Combretaceae | Plantae | 99434 |
Showing of synonyms
Arjunolic acid
CHEBI:68381
(4aS,6aR,6aS,6bR,8aR,9R,10R,11R,12aR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
DTXSID80963583
2,3,23-Trihydroxyolean-12-en-28-oic acid
(2alpha,3beta,4alpha)-2,3,23-trihydroxyolean-12-en-28-oic acid
Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2alpha,3beta,4alpha)-
2alpha,3beta-24-trihydroxyolean-12-en-28-oic acid
(2alpha,3beta)-2,3,23-trihydroxyolean-12-en-28-oic acid
Arjunolate
DTXCID401391327
10,11-Dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate
465-00-9
CHEMBL464466
MFCD11113458
SCHEMBL565233
8N8Q74HVN3
HY-N2896
MSK40236
BDBM50250899
AKOS032962083
FA35178
Arjunolic acid, >=95% (LC/MS-ELSD)
CS-0023481
E88720
Q27136879
2,3,23-Trihydroxyolean-12-en-28-oic acid, (2alpha,3beta,4alpha)-
Olean-12-en-28-oic acid, 2,3,23-trihydroxy-, (2.alpha.,3.beta.,4.alpha.)-
(2,3,4)-2,3,23-Trihydroxyolean-12-en-28-oic acid
Urjinolic acid
(4aS,6aS,6bR,8aR,9R,10R,11R,12aR,12bR,14bS)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid
- Ndjateu F, Tsafack R, et al. (2014). Antimicrobial, antioxidant, anti-inflammatory activities and phytoconstituents of extracts from the roots of Dissotis thollonii Cogn. (Melastomataceae). South African Journal of Botany, 2014, 93, 19-26. [View]
- Uzor PF, Ebrahim W, et al. (2015). Metabolites from Combretum dolichopetalum and its endophytic fungus Nigrospora oryzae — evidence for a associated metabolic partnership. Fitoterapia,2015,105,147-150. [View]
- Kuigoua GM, Kouam SF, et al. (2010). Minor secondary metabolic products from the stem bark of Plumeria rubra Linn. displaying antimicrobial activities. Planta medica,2010, 76(6), 620-625. [View] [PubMed]
Pubchem:
73641
Cas:
465-00-9
Gnps:
CCMSLIB00010007995
Zinc:
ZINC000031158038
Chebi:
68381
Nmrshiftdb2:
60022818
Metabolights:
MTBLC68381
Chembl:
CHEMBL464466
Bindingdb:
50250899
CPRiL:
100823
SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CCCC5
Level: 0
Mol. Weight: 488.71 g/mol
Antimicrobial
Absorption
- Caco-2 (logPapp)
- -5.53
- Human Oral Bioavailability 20%
- Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -4.92
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- -1.88
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 1.45
- Plasma Protein Binding
- 92.59
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Non-Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Non-Substrate
- CYP 2C19 Inhibitor
- Non-Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Non-Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Substrate
- OATP1B1
- Inhibitor
- OATP1B3
- Inhibitor
Excretion
- Clearance
- 3.09
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Toxic
- Bioconcentration Factor
- -2.14
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Safe
- Liver Injury I (DILI)
- Toxic
- Eye Corrosion
- Safe
- Eye Irritation
- Safe
- Maximum Tolerated Dose
- 1.15
- Liver Injury II
- Safe
- hERG Blockers
- Toxic
- Daphnia Maga
- 5.01
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Toxic
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Toxic
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- -203.56
- Rat (Acute)
- 2.57
- Rat (Chronic Oral)
- 2.99
- Fathead Minnow
- 3.93
- Respiratory Disease
- Toxic
- Skin Sensitisation
- Safe
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 468.46
- Hydration Free Energy
- -3.07
- Log(D) at pH=7.4
- 3.44
- Log(P)
- 4.59
- Log S
- -4.91
- Log(Vapor Pressure)
- -10.73
- Melting Point
- 274.12
- pKa Acid
- 4.91
- pKa Basic
- 7.56
No predicted protein targets found for this compound.